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Clinical Investigation
Introduction
Endovascular aneurysm repair (EVAR) is the treatment of 
choice for patients presenting an abdominal aortic aneu-
rysm (AAA) with favorable anatomy.1–4 By contrast, EVAR 
needs a closer follow-up due to a higher incidence of rein-
terventions when compared with conventional surgey.5,6 
Type I endoleak is the most significant EVAR complication 
as it increases aneurysm rupture risk; thus, treatment of type 
I endoleak is strongly recommended.7
Chimney and/or periscope grafts (CPGs) have been 
shown to be valuable endovascular options to treat parare-
nal and thoracoabdominal aortic aneurysms (TAAAs) in 
selected patients, but so far there is limited knowledge on 
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Abstract
Purpose: To evaluate the midterm outcomes of chimney and/or periscope grafts (CPGs) in patients presenting type 
I endoleak after a previous endovascular aneurysm repair (EVAR). Methods: Between June 2002 and April 2014, 24 
consecutive patients (mean age 73.9±9.2 years; 23 men) presenting a type I endoleak were addressed with CPGs to 
extend the proximal and/or distal landing zone and to maintain side branch perfusion. Indication for treatment was a 
type Ia endoleak in 23 (96%) patients and a type Ib endoleak in one. Median interval from the previous EVAR to endoleak 
treatment with CPGs was 52.2±48.9 months (range 0.2–179). All patients had proximal/distal landing zones precluding 
any standard endovascular reintervention. Measured outcomes included technical success and perioperative mortality and 
morbidity. Technical success was defined as a procedure completed as intended, with no secondary procedures within 30 
days. Midterm outcomes included survival, CPG patency, endoleaks, and freedom from reintervention. Results: Technical 
success was 96%; a single patient required an additional procedure to seal a recurrent type Ia endoleak. Intraoperative 
revascularization of all 55 target vessels (2.3/patient) with CPGs was successful. One (4%) patient died within 30 days. 
Estimated survival at 12, 24, and 36 months was 83%; estimated CPG patency at the same intervals was 94%. Over a mean 
follow-up of 23.4±29 months, 6 (25%) reinterventions were performed; of these, 4 were secondary to type I endoleak. 
Aneurysm diameters reduced from 88.3±26 to 85.5±33 mm (p=0.49) over the mean follow-up. Conclusion: The CPG 
technique is a safe and effective tool for treatment of type I endoleak after previous EVAR. The CPG technique is feasible 
even in nonelective patients, with excellent outcomes in terms of patency. Close imaging follow-up is warranted to rule 
out recurrent or de novo endoleaks.
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their use to treat type I endoleak. Herein we report midterm 
results of CPGs used to treat post-EVAR type I endoleak.
Methods
Study Cohort
Between June 2002 and April 2014, 24 consecutive patients 
(mean age 73.9±9.2 years; 23 men) with type I endoleak (23 
proximal and 1 distal) associated with 23 pararenal AAAs 
and 1 TAAA, respectively, were treated with the CPG tech-
nique to maintain perfusion to the renovisceral branches. 
Three patients with type Ia endoleak also presented a distal 
type Ib endoleak. The cause of type I endoleak was related 
to stent-graft migration in 13 (54%) cases and neck degen-
eration in 11 (46%).
Seventeen (71%) patients were treated electively and 7 
(29%) urgently; of the latter patients, 5 were symptomatic 
and 2 had an aortic rupture. All patients were considered 
at high risk for conventional open aortic surgery.8 
Fourteen (58%) were classified as American Society of 
Anesthesiologists class III/IV owing to multiple comor-
bidities and risk factors (Table 1). Mean preoperative esti-
mated glomerular filtration rate (eGFR) was 54±12 mL/
min/1.73 m2; 13 (54%) patients had decreased renal func-
tion, with serum creatinine levels >100 μmol/L. The mean 
sac diameter before the CPG treatment was 88±26 mm.
Mean time from the previous EVAR procedure to the 
CPG treatment was 52±49 months (range 0.2–179). In the 
initial EVAR procedure, 9 patients received an infrarenally 
fixed stent-graft (Excluder; W.L. Gore & Associates, 
Flagstaff, AZ, USA), while the remaining 15 had suprarenal 
fixation [6 Endurant and 2 Talent (Medtronic Vascular, 
Santa Rosa, CA, USA); 5 Zenith Flex (Cook Medical, 
Bloomington, IN, USA); 2 Vanguard (Boston Scientific, 
Natick, MA, USA)].
All patients underwent preoperative thoracoabdominal 
computed tomographic angiography (CTA), and CTA data 
were analyzed on a dedicated workstation (VOXAR 3D; 
Toshiba Medical Visualization Systems Europe, Ltd, 
Edinburgh, UK). The operative strategy was tailored to each 
patient after assessment of anatomical details and aneurysm 
morphology. All the patients were considered anatomically 
unfit for a “standard” endovascular procedure due to the lack 
of an adequate (≥5 mm) infrarenal landing zone.
The selection of a chimney or periscope configuration 
was planned according to the anatomy of the aortic aneu-
rysm and the renovisceral target vessel(s), the access route 
anatomy, and the number of revascularized vessels. Main 
anatomical details considered were the target vessel angle 
with the aorta, iliac tortuosity, aortic tortuosity, unstable 
plaques though the access route, and access vessel diameter. 
In case of multiple renal and visceral revascularizations, the 
chimney configuration was preferred for the visceral ves-
sels and the periscope configuration for the renal arteries.
Patient imaging data, physiological parameters, and out-
come data were collected prospectively in a clinical infor-
mation system (Dendrite and KISIM 4.901; Dendrite 
Clinical Systems, Ltd, Henley-on-Thames, UK) and ana-
lyzed retrospectively in June 2014. Informed consent for 
the procedure itself and the anonymous data collection and 
analysis was obtained from all patients.
Technique
All procedures were performed in an angiography suite or a 
hybrid operating room, both equipped with high-resolution 
imaging equipment [Siemens (Erlangen, Germany) or 
Philips (Shelton, CT, USA)]. The CPG procedures were 
performed under general anesthesia in 13 (54%) patients 
and local anesthesia in 11 (46%). The aortic stent-graft was 
deployed from a femoral artery access, while the CPGs 
were introduced through the femoral vessels and/or the left 
axillary artery. In some cases of multiple CPGs, both axil-
lary and femoral accesses were used to address the target 
vessels (Figure 1).9 The chimney configuration was 
achieved through the axillary or femoral artery (lift tech-
nique10) and the periscope through the femoral site.
The renovisceral branches were cannulated typically 
using a 45-cm Arrow sheath (Arrow International Inc, 
Reading, PA, USA) parked in the descending aorta close to 
the visceral orifice, a 5-F Chuang visceral reverse curve 
catheter (Cook Inc), and a Rosen wire (Cook Inc). After vis-
ceral branch cannulation, the CPG was positioned into the 
target artery, the aortic stent-graft was parked in the distal 
aorta, and the CPG was deployed with its distal end ~2 cm 
into the target vessel. In most cases, self-expanding covered 
stents (Viabahn; W.L. Gore & Associates, Flagstaff, AZ, 
Table 1. Demographics and Comorbidities in the 24-Patient 
Cohort.a
Age, y 73.9±9.2
≥80 y 6 (25)
Men 23 (96)
Hypertension 22 (92)
Diabetes 7 (29)
Dyslipidemia 16 (67)
Smoking 13 (54)
Decreased renal function 13 (54)
Cardiac disease 14 (58)
COPD 13 (54)
Hostile chest/abdomen 6 (25)
Peripheral artery disease 11 (46)
ASA III/IV 14 (58)
Abbreviations: ASA, American Society of Anesthesiologists; COPD, 
chronic obstructive pulmonary disease.
aContinuous data are presented as the mean ± standard deviation; 
categorical data are given as the counts (percentage).
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USA) were used for CPG construction. Sporadically, bare 
metal stents (BMS) were employed [Wallstent (Boston 
Scientific Corporation, Natick, MA, USA) and Palmaz 
Blue or Corinthian SES (Cordis Corporation, Bridgewater, 
NJ, USA)]. The CPGs in the last 6 patients were lined with 
BMS to increase fluoroscopic visibility.11,12
After CPG deployment, a 2-cm-long balloon catheter 
(Admiral Xtreme; Medtronic Vascular) was used to fully 
expand the CPGs at their anchoring/landing zone. The 
deflated balloons remained in the target arteries, where 
they were reinflated and tensioned to hold the CPGs 
straight and parallel to the aortic wall during deployment of 
the new aortic stent-grafts [Excluder and TAG (W.L. Gore 
& Associates), Evita (Jotec, Hechingen, Germany), and 
Endurant (Medtronic Vascular)]. The design and anatomi-
cal details of the stent-grafts are reported in Table 2. 
Diameter sizing of the aortic stent-graft was based on the 
mean aortic diameter and the mean diameter of the CPGs 
as reported elsewhere.13 A kissing balloon technique com-
pleted the procedure by achieving full and simultaneous 
expansion of the aortic graft and CPGs, especially in the 
overlapping areas. Completion angiography and selective 
pressure measurements (proximal and distal to the aortic 
stent-graft and in all CPGs) were performed to exclude 
endoleaks and/or significant pressure gradients.
Follow-up Protocol
A standardized follow-up protocol, including CTA, labora-
tory testing, and clinical examination was executed at 3, 6, 
and 12 months and annually thereafter. In case of endoleak or 
neck degeneration detected during follow-up, imaging fre-
quency was tailored to the finding. In case of CTA contrain-
dication, a native CT and duplex ultrasonography (eventually 
with contrast enhancement) were combined to assess stent-
graft function. Medications consisted of aspirin (100 mg/d) 
and full heparinization during hospitalization; the heparin 
was switched to clopidogrel (75 mg/d) or an oral anticoagu-
lant at discharge and continued for at least 3 months.
Outcomes
Evaluated outcomes included technical success, periopera-
tive mortality, and morbidity. Technical success was defined 
as a procedure completed as intended with no secondary 
procedures within 30 days. Midterm outcomes were sur-
vival, CPG patency, endoleaks, and freedom from reinter-
vention; Kaplan-Meier curves were employed to estimate 
survival and patency.
Mean and standard deviations are reported for paramet-
ric data; absolute values and percentages for nonparametric 
data. Differences were assessed using the t test. Statistical 
significance was assigned at p<0.05. Data analysis was per-
formed using SPSS (version 16.0; IBM Corporation, 
Somers, NY, USA).
Results
Overall, 55 target vessels (2.3/patient) were addressed [44 
renal arteries, 8 superior mesenteric arteries (SMAs), and 3 
celiac trunks]. The chimney graft configuration was used in 
31 and the periscope/sandwich graft configuration in 24. In 3 
vessels, the chimney configuration was achieved with the lift 
technique from the femoral artery. No CPG was performed as 
a bailout procedure. Branches and CPG details are reported 
in Table 3. The intraoperative target vessel perfusion success 
rate with the CPGs was 100%. Technical success was 
achieved in 96% of the patients. One patient with a high-flow 
type Ia endoleak at postoperative CTA was managed success-
fully by proximal aortic cuff, CPG extension, and CPG gutter 
embolization with ethylene vinyl alcohol copolymer (Onyx) 
early after the first procedure (Figure 2).
Mean procedure duration was 240±107 minutes (range 
105–480). Mean intensive care unit stay was 1.9±4 days 
and mean in-hospital length of stay was 8.7±9 days. The 
mean postoperative eGFR was 58±17 mL/min/1.73 m2 and 
did not differ significantly from the preoperative eGFR 
(p=0.78).
Thirty-day mortality was 4.1% (1/24); this patient had 
double renal chimney grafts and died from multiple organ 
Figure 1. Four-vessel chimney periscope graft technique. A 
transfemoral periscope configuration was employed for renal 
arteries and a transaxillary chimney configuration for the 
celiac trunk and superior mesenteric artery. (A) Intraoperative 
angiogram showing final deployment of all renovisceral chimney 
and periscope grafts in the respective vessels. Balloons are 
inflated inside the periscope grafts (arrows) in the renal arteries 
to achieve anchoring. (B) Intraoperative angiogram showing cuff 
implantation and sandwich periscope for renal arteries (arrows).
Montelione et al 571
failure after SMA occlusion on the seventh postoperative 
day. Six (25%) patients experienced a complication. An 
iliac occlusion, a femorofemoral crossover bypass occlu-
sion, and an axillary hematoma with neurological symp-
toms required reinterventions, while 2 renal hematomas and 
a case of postimplantation inflammatory syndrome were 
managed conservatively with prolonged hospitalization.
Mean follow-up after CPG placement was 23±28 months 
(range 0.2–122). During this time, 3 patients died of unre-
lated causes. Estimated survival at 12, 24, and 36 months 
was 83% (Figure 3A). Two CPGs occluded at 1 and 10 
months postoperatively. Estimated CPG patency at 12, 24, 
and 36 months was 94% (Figure 3B). Four type I endoleaks 
(3 type Ia and a type Ib) were detected during follow-up; in 
2 cases these were related to neck degeneration and in 2 
cases to persisting gutter.
During follow-up, 6 (25%) reinterventions were per-
formed at a mean of 15±12 months after CPG placement. 
All but one reintervention were performed endovascularly. 
Four reinterventions were related to type I endoleak and 
consisted of an infrarenal neck banding, 2 perileak embo-
lizations with Onyx, and a proximal cuff extension and 
SMA stenting. The remaining 2 reinterventions were 
related to CPG occlusion and consisted of bypass surgery 
Table 2. Main Graft Details.
Failing Graft Treatment Graft Design Size, mm CG PG
Excluder Evita Tube 30 2 0
Zenith Endurant Cuff 36 0 3
Endurant Endurant Cuff 36 0 2
Endurant Endurant Cuff 32 0 2
Talent Endurant Cuff 32 0 2
Vanguard Endurant AUI 32 0 1
Excluder Excluder Bif 26 1 0
Excluder Excluder Bif 23 0 1
Excluder Evita Cuff 30 1 0
Vanguard Excluder Bif 26 2 0
Zenith Excluder Bif 24 2 0
Excluder Evita Cuff 30 2 0
Zenith Evita Cuff 36 2 1
Excluder Evita Cuff 33 2 0
Excluder Evita Cuff 32 2 1
Excluder + Evita cuff Excluder Bif 28 2 0
Excluder Endurant Bif 36 2 0
Endurant + TEVARa TAG Tube 37 2 2
Zenith TAG Tube 32 2 2
Zenith Evita Cuff 36 1 2
Endurant TAG Tube 45 2 2
Endurant Endurant Cuff 32 1 2
Endurant Endurant Cuff 36 1 0
Talent Endurant Cuff 36 2 1
Abbreviations: AUI, aortouni-iliac; Bif, bifurcated; CG, chimney graft; PG, periscope graft; TEVAR, thoracic endovascular aortic repair.
aType Ib endoleak in patients with previous TEVAR and endovascular aneurysm repair.
Table 3. Parallel Graft Details.
Target Branch N
Configuration Stent Types Dimensions
Chimney Periscope Covered Bare Diameter, mm Length, cm
RRA 22 11 11 31 8 6.36±0.87 6.22±2.47
LRA 22 12 10 28 7 6.48±0.68 6.24±2.33
SMA  8  5  3 13 3 8.44±0.88 6.00±2.18
CT  3  3  0  4 1 8.40±1.52 8.00±2.74
Abbreviations: CT, celiac trunk; LRA, left renal artery; RRA, right renal artery; SMA, superior mesenteric artery.
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Figure 2. (A) Computed tomography (CT) showing abdominal aortic aneurysm rupture due to proximal type Ia endoleak after 
failed previous standard endovascular repair. (B) Intraoperative angiogram showing persistent type Ia endoleak after parallel graft 
implantation. (C) Persistent type Ia endoleak management with cuff implantation, superior mesenteric artery stenting, and Onyx 
embolization. (D) CT control showing complete sealing of the type Ia endoleak. (E) One-year CT showing significant aneurysm sac 
shrinkage. (F) Three-dimensional CT angiography volume rendering.
Figure 3. Kaplan-Meier estimates of (A) cumulative overall survival and (B) parallel graft patency. The standard errors did not exceed 
10% at 36 months.
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(mesenteric artery-to-renal artery bypass) and balloon 
dilation (Table 4).
Mean maximal aneurysm sac diameter decreased from 
88±26 to 85±33 mm (p=0.49) over the course of follow-up. 
Aneurysm sac diameter remained stable or decreased in 21 
(87%) patients, while the other 3 had significant sac diam-
eter increases (>5 mm). One of the latter cases was related 
to a recurrent type Ia endoleak.
Discussion
Despite significant improvements in stent-graft technology 
and surgeon experience, standard EVAR is still associated 
with a significant reintervention rate during follow-up. In 2 
recent published experiences, Chang et al14 and Mehta et 
al15 reported reintervention rates of 14.5% and 19% at 3 and 
2.8 years, respectively. Tadros et al16 reported that the type 
I endoleak incidence, although reduced, was still present in 
the different device generations, with an incidence ranging 
from 3.5% to 15.5%. Thus, the association of type I endo-
leaks with an increased aneurysm rupture risk is a strong 
recommendation for treatment.17,18
In such cases, an open aortic repair is generally per-
formed in EVAR failure, despite a high mortality of up to 
22%.19 However, advanced age, suprarenal or supraceliac 
aortic clamping, and the technical challenge of endograft 
removal (stent incorporation into the aortic wall, presence 
of external stents or barbs, and periaortic inflammation) 
expose the patients to a high surgical risk, especially in the 
nonelective setting.20 To reduce the operative risk, several 
options have been proposed. If an adequate proximal and/or 
distal landing zone is available, cuff implantation is a rea-
sonable alternative to open surgery. Conversely, when a 
landing zone is missing, coil embolization, fenestrated 
EVAR, or CPGs have been used. Embolization of the sac 
with coils, n-butyl cyanoacrylate,21 Onyx,22 or fixation pro-
cedures with endoanchors23 have been employed in isolated 
cases with good early results, but so far durability of such 
methods is not proven.
Fenestrated stent-grafts have been used in patients with 
type I endoleak.24 However, the radiopaque stent skeleton 
and markers of the previous stent-graft make it challeng-
ing to recognize the fenestration markers, and as a conse-
quence, positioning and accurate deployment of the 
fenestrated device are quite cumbersome. On the contrary, 
aortic devices used for the CPG technique are standard, 
nonfenestrated devices (tube or cuff) that do not have to be 
oriented or aligned to the renal and/or visceral orifices, 
which makes the procedure in this regard much easier.25 
When suprarenal fixation devices have been employed for 
the previous EVAR treatment, the struts are generally 
overlying the renal arteries. In such cases, renal catheter-
ization can be hazardous after the deployment of a fenes-
trated stent-graft. Indeed, Katsargyris et al26 reported 
technical difficulties in target vessel catheterization in 
13% of cases.
By contrast, vessel catheterization in the CPG technique 
is achieved from above or below following the easier route 
to the visceral vessels, and it can be performed outside the 
existing failed stent-graft and before placement of a new 
aortic stent-graft. Moreover, in case of failure to catheterize 
the visceral arteries, a CPG procedure can be stopped before 
the placement of the new aortic stent-graft. In addition, the 
CPG technique employs standard nonfenestrated aortic and 
bridging stents-grafts, making this procedure feasible even 
in nonelective cases.27
To date, there are only a few experimental and no consis-
tent clinical data supporting the use of one device over the 
other for the parallel graft technique.28 In our experience, 
we have employed different standard aortic stent-grafts 
(Excluder, Endurant, and Evita), but for chimney and/or 
periscope endografts, we essentially used self-expanding 
covered stents such as the Viabahn because of its low pro-
file, flexibility, and heparin coating. We prefer combining 
the Viabahn with the Excluder aortic stent-graft, but overall, 
there were no significant differences in terms of CPG 
patency rate or endoleak incidence between the different 
aortic stent-grafts used. Balloon-expandable stent-grafts 
(BESG) may be used as chimney grafts, as the Münster 
group9 showed in a study comparing self-expanding and 
BESGs.9
Technical success after endovascular repair of type I 
endoleak using CPGs is good, with no aneurysm-related 
mortality, no secondary rupture, overall aneurysm sac 
reduction, and high target vessel patency. Reintervention 
for persisting or secondary endoleak was necessary in a sig-
nificant percentage of the patients in this study, but this 
remains true for cases treated with fenestrated EVAR as 
well. Therefore, long-term imaging follow-up remains 
mandatory.
Table 4. Reinterventions During Follow-up.
Indication Treatment
Time to 
Reintervention, mo
Type Ib endoleak Banding 18
Type Ia endoleak Gutter embolization 
(Onyx)
 5
Type Ia endoleak Gutter embolization 
(Onyx)
28
Type Ia endoleak Redo CG-EVAR 29
RRA stent 
occlusion
SMA-RRA bypass  1
SMA stenosis SMA angioplasty 10
Abbreviations: CG-EVAR, chimney graft endovascular aneurysm repair; 
RRA, right renal artery; SMA, superior mesenteric artery.
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Conclusion
Use of the CPG technique avoids open aortic repair in 
patients presenting attachment site endoleak after EVAR. In 
comparison with open surgery, CPGs were safer and effec-
tive, even in nonelective patients, with high primary and 
midterm patency rates at 3 years. The CPG technique has a 
high initial success rate, with the occasional need for sec-
ondary intervention in patients presenting recurrent or de 
novo endoleaks. Close imaging follow-up is warranted.
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